Home > Insider Trading > Filing (0001415889-17-001296)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1109196	Mabvax Therapeutics Holdings Inc.	MBVX	Pharmaceutical Preparations (2834)	930987903

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1186120	P Gregory Hanson	C/O Mabvax Therapeutics Holdings, Inc. 11535 Sorrento Valley Rd., Suite 400 San Diego CA 92121	Chief Financial Officer, Secr	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-05-19	4,286	$1.75	33,492	No	4	P	Direct
Common Stock	Acquisiton	2017-05-19	4,842	$0.00	38,334	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Class A Warrant	Disposition	2017-05-19	3,119	$0.00	3,119	$5.55
Common Stock	Class B Warrant	Disposition	2017-05-19	3,119	$0.00	3,119	$6.29

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	S	Direct
0			No	4	S	Direct

Footnotes

These shares were received in exchange for making an investment under the terms of the Company's May 2017 public offering equal to 50% of investment made in the Company's August 2016 public offering, and for the cancellation of (i) warrants to purchase 3,119 shares of the Company's common stock at a price per share of $5.55 issued to the Reporting Person on August 17, 2016 and (ii) warrants to purchase 3,119 shares of the Company's common stock at a price per share of $6.29 issued to the Reporting Person on August 17, 2016.
Warrant is immediately exercisable and expires on August 17, 2019.
These warrants were cancelled and exchanged for the right to receive 4,842 shares of common stock of the Company.